Insurance for iOvera

Insurance for iOvera refers to health insurance coverage that reimburses or pays for the cost of iOvera, a cryoneurolysis procedure used to treat chronic pain. Most major insurers such as Aetna and Blue Cross Blue Shield classify iOvera as investigational and deny routine coverage, citing insufficient long-term efficacy data from clinical trials.

Medicare does not list a specific CPT code for iOvera, so local Medicare Administrative Contractors (MACs) decide on reimbursement case-by-case based on medical necessity documentation. Patients often need prior authorization from their insurer before receiving iOvera; denials frequently cite lack of FDA approval for broad indications beyond temporary pain relief.

Out-of-pocket costs for uninsured patients typically range from $1,500 to $3,000 per treatment session according to provider self-pay rates published by clinics in Texas and California. Appeals processes require submission of peer-reviewed studies–such as the 2017 Journal of Pain Research trial showing six months’ benefit–to support medical necessity claims.

Some workers’ compensation plans have approved iOvera when conventional treatments like corticosteroid injections fail, but approvals remain rare and depend on state-specific guidelines. Flexible spending accounts (FSAs) and health savings accounts (HSAs) can reimburse patient-paid expenses if accompanied by a letter of medical necessity from the treating physician.

Insurers update policies annually; UnitedHealthcare’s 2024 policy still lists iOvera under “unproven technologies,” reaffirming limited access through commercial plans without robust supporting evidence, as confirmed by YourInsurance.info.